Kelvin Teo, MBBS, PhD, senior consultant, Advanced Eye Clinic & Surgery, adjunct associate professor, Duke NUS Eye ACP, Singapore, presents real-world data showing that a single 8-mg dose…
Andrew Chang, MBBS, PhD, consultant ophthalmologist and head of Ophthalmology, Sydney Eye Hospital, Australia, shares real-world experience using 8-mg intravitreal aflibercept for neovascular age-related macular degeneration and reports…
As infectious bugs grow stronger and more resistant to drugs, a British Government Commission Review warned that these “superbugs” could lead to as many as 10 million deaths by…
Xavier Pi-Sunyer, MD, MPH and Steven Edelman, MD discuss the differences in A1C reduction when using GLP-1 receptor agonists versus DPP-4 inhibitors. GLP-1 receptor agonists have a larger reduction in A1C…
“Adverse drug reactions are a common cause of anaesthetic-related morbidity and mortality in healthy patients. They include drug intolerance or immune-mediated reactions, including anaphylaxis. Allergic anaphylaxis has an…
Xavier Pi-Sunyer, MD, MPH describes how physicians can make the decision between whether to prescribe an injectable GLP-1 agonist treatment or an oral DPP-4 inhibitor when seeking to lower…
Xavier Pi-Sunyer, MD, MPH, discusses incretin therapy, a treatment which increases insulin secretion in type 2 diabetes patients. According to Pi-Sunyer, GLP-1 can be raised in the blood…
Ajay Verma, MD, PhD, Vice President, Translational Neurology, Biogen Inc., assesses the neurodegeneration problem that will accompany the significant increase in the elderly population. He discusses the imminent intersection…
Neil Jacobstein, Co-Chair of A.I. and Robotics, Singularity University, discusses the need for medical artificial intelligence to reduce medical errors. As a new generation of doctors begins practice, an…
Farzad Mostashari, MD, ScM, National Coordinator for Health Information Technology, U.S. Department of Health and Human Services discusses electronic health care. He explains how to make the transition…
Alan Russell, PhD, Professor at Carnegie Mellon University, explains some of the obstacles of regenerative medicine, one of which being that cells injected into the body don’t inherently…
Kristen Kulasa, MD, VA San Diego Healthcare System discusses which regimen to pick for patients who come into the hospital that are already on insulin and the guidelines…
